177 related articles for article (PubMed ID: 22744394)
1. London 2012: prescribing for athletes in ophthalmology.
Nicholson RG; Thomas GP; Potter MJ; Norris JH
Eye (Lond); 2012 Aug; 26(8):1036-8. PubMed ID: 22744394
[TBL] [Abstract][Full Text] [Related]
2. The World Anti-Doping Code 2003--consequences for physicians associated with elite athletes.
Striegel H; Rössner D; Simon P; Niess AM
Int J Sports Med; 2005 Apr; 26(3):238-43. PubMed ID: 15776342
[TBL] [Abstract][Full Text] [Related]
3. Prescribing for athletes and plastic surgery.
Thomas GP; Mace A; Smith R; Potter MM
J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1430-1. PubMed ID: 22658844
[No Abstract] [Full Text] [Related]
4. Treating the elite athlete: anti-doping information for the health professional.
Tandon S; Bowers LD; Fedoruk MN
Mo Med; 2015; 112(2):122-8. PubMed ID: 25958657
[TBL] [Abstract][Full Text] [Related]
5. Structure and Development of the List of Prohibited Substances and Methods.
Kinahan A; Budgett R; Mazzoni I
Med Sport Sci; 2017; 62():39-54. PubMed ID: 28571027
[TBL] [Abstract][Full Text] [Related]
6. [Ophthalmic drug therapy in professional athletes-what is allowed, what is doping?].
Wall K; Rokohl AC; Scheiff AB; Katlun T; Heindl LM
Ophthalmologie; 2022 Dec; 119(12):1250-1256. PubMed ID: 35947154
[TBL] [Abstract][Full Text] [Related]
7. [Medication, athletes and doping regulations].
Hartgens F
Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
[TBL] [Abstract][Full Text] [Related]
8. Rheumatological prescribing in athletes: a review of the new World Anti-Doping Agency guidelines.
Smith R; Barnsley L; Kannangara S; Mace A
Rheumatology (Oxford); 2004 Dec; 43(12):1473-5. PubMed ID: 15292526
[TBL] [Abstract][Full Text] [Related]
9. World anti-doping regulations for 2005: essential changes for athletes and physicians.
Pabinger C; Gruber G
Arch Orthop Trauma Surg; 2006 May; 126(4):286-8. PubMed ID: 16333634
[TBL] [Abstract][Full Text] [Related]
10. Meldonium use by athletes at the Baku 2015 European Games.
Stuart M; Schneider C; Steinbach K
Br J Sports Med; 2016 Jun; 50(11):694-8. PubMed ID: 27015859
[TBL] [Abstract][Full Text] [Related]
11. Doping control from a global and national perspective.
Fraser AD
Ther Drug Monit; 2004 Apr; 26(2):171-4. PubMed ID: 15228160
[TBL] [Abstract][Full Text] [Related]
12. [World Football Championship 2006--anti-doping regulations].
Wolfarth B; Graf-Baumann T; Halle M
MMW Fortschr Med; 2006 Jun; 148(23):41-3. PubMed ID: 16826737
[TBL] [Abstract][Full Text] [Related]
13. The asthmatic athlete: inhaled Beta-2 agonists, sport performance, and doping.
McKenzie DC; Fitch KD
Clin J Sport Med; 2011 Jan; 21(1):46-50. PubMed ID: 21200170
[TBL] [Abstract][Full Text] [Related]
14. Investigating the use of stimulants in out-of-competition sport samples.
Boghosian T; Mazzoni I; Barroso O; Rabin O
J Anal Toxicol; 2011 Nov; 35(9):613-6. PubMed ID: 22080900
[TBL] [Abstract][Full Text] [Related]
15. Pharmacists supporting athletes: a scoping review exploring the knowledge, role and responsibilities of pharmacists in preventing the unintentional use of prohibited substances by athletes.
Greenbaum DH; McLachlan AJ; Roubin RH; Chaar BB
Int J Pharm Pract; 2022 May; 30(2):108-115. PubMed ID: 35262700
[TBL] [Abstract][Full Text] [Related]
16. Australian athletes' knowledge of the WADA Prohibited Substances List and performance enhancing substances.
Orr R; Grassmayr M; Macniven R; Grunseit A; Halaki M; Bauman A
Int J Drug Policy; 2018 Jun; 56():40-45. PubMed ID: 29550541
[TBL] [Abstract][Full Text] [Related]
17. Blood doping at the Olympic Games.
Fitch KD
J Sports Med Phys Fitness; 2017 Nov; 57(11):1526-1532. PubMed ID: 28094487
[TBL] [Abstract][Full Text] [Related]
18. Medication use in athletes selected for doping control at the Sydney Olympics (2000).
Corrigan B; Kazlauskas R
Clin J Sport Med; 2003 Jan; 13(1):33-40. PubMed ID: 12544162
[TBL] [Abstract][Full Text] [Related]
19. [Medicolegal aspects of doping in sports].
Pruvost J; Depiesse F
Ann Readapt Med Phys; 2004 Aug; 47(6):263-73. PubMed ID: 15297116
[TBL] [Abstract][Full Text] [Related]
20. The evolution of European legislation on doping: new challenges in the age of NPS.
Marinelli S; Basile G; Varì MR; Napoletano G; Negro F; Tini A
Eur Rev Med Pharmacol Sci; 2022 Sep; 26(18):6405-6417. PubMed ID: 36196691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
